Visual impairment in persons with psychotic disorder

Social Psychiatry and Psychiatric Epidemiology

Volumn 42, Issue 11, 2007, Pages 902-908

  Viertiö, Satu ^a   Laitinen, Arja ^a   Perälä, Jonna ^a   Saarni, Samuli I ^a   Koskinen, Seppo ^a   Lönnqvist, Jouko ^a,b   Suvisaari, Jaana ^a,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Epidemiologic studies; Medicalco morbidity; Psychoticdis orders; Schizophrenia; Visual acuity

Indexed keywords

NEUROLEPTIC AGENT; PHENOTHIAZINE;

ADULT; AGE DISTRIBUTION; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; BINOCULAR VISION; BLURRED VISION; COMORBIDITY; CONTACT LENS; CORRELATION FUNCTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOPIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PSYCHOSIS; REFRACTION ERROR; RISK; SCHIZOPHRENIA; SEX RATIO; SIDE EFFECT; SPECTACLES; STATISTICAL ANALYSIS; VISION; VISION TEST; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CATARACT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; INTERVIEW, PSYCHOLOGICAL; MACULAR DEGENERATION; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEX DISTRIBUTION; VISION DISORDERS; VISION SCREENING; VISUAL ACUITY;

EID: 37449002812     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-007-0252-6     Document Type: Article

References (35)

1. Aromaa A, Koskinen S (eds) (2004) Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Publications of the National Public Health Institute, B12/2004. http://www.ktlwww.ktl.fi/tto/terveys2000/index.uk.html
2. Brenner CA, Lysaker PH, Wilt MA, O'Donnell BF (2001) Visual processing and neuropsychological function in schizophrenia and schizoaffective disorder. Psychiatry Res 111:125-136
3. Brown S, Birtwistle J, Roe L, Thompson C (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29:697-701
4. Buch H, Vinding T, la Cour M, Appleyard M, Jensen GB, Vesti Nielsen N (2004) Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults. Ophthalmology 111:53-61
5. Bushe C, Holt R (2004) Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br J Psychiatry 184(suppl.47):67-71
6. Butler PD, Zemon V, Schechter I, Saperstein AM, Hoptman MJ, Lim KO, Revheim N, Silipo G, Javitt DC (2005) Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 62:495-504
7. Callison DA, Armstrong HF, Elam L, Cannon RL, Paisley CB, Himwich HE (1971) The effects of aging on schizophrenic and mentally defective patients: Visual, auditory, and grip strength measurements. J Gerontol 26:137-145
8. Druss BG, Bradford D, Rosenheck RA, Radford MJ, Krumholz HM (2001) Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 58:565-572
9. Ferris FL, Kassoff A, Bresnick GH, Bailey I (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91-96
10. Glassman AH, Bigger JT (2001) Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158:1774-1782
11. Heilä H, Haukka J, Suvisaari J, Lönnqvist J (2005) Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 35:725-732
12. Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC (2005) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents. Arch Gen Psychiatry 62:19-28
13. Isaac NE, Walker AM, Jick H, Gorman M (1991) Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol 109:256-260
14. Kupfer DJ (2005) The increasing medical burden in bipolar disorder. J Am Med Association 293:2528-2530
15. Laitinen A, Koskinen S, Härkänen T, Reunanen A, Laatikainen L, Aromaa A (2005) A nationwide population-based survey on visual acuity, near vision, and self-reported visual function in the adult population in Finland. Ophthalmology 112:2227-2237
16. Legood R, Scuffham P, Cryer C (2002) Are we blind to injuries in the visually impaired? A review of the literature. Inj Prev 8:155-160
17. Lieberman JA (2004) Managing anticholinergic side effects. Prim Care Companion J Clin Psychiatry 6(suppl 2):20-23
18. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S (2004) Physical health monitoring of patients with schizophrenia. Am J Psychiatry 161:1334-1349
19. Ösby U, Brandt L, Correia N, Ekbom A, Sparen P (2001) Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58:844-850
20. Perälä J, Suvisaari J, Saarni IS, Kuoppasalmi K, Isometsä E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppä T, Härkänen T, Koskinen S, Lönnqvist J (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 64:19-28
21. Pirkola SP, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koskinen S, Aromaa A, Lönnqvist JK (2005) DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population. Soc Psychiatry Psychiatr Epidemiol 40:1-10
22. Punukollu B, Phelan M (2006) Visual acuity and reported eye problem among psychiatric in-patients. Psychiatric Bull 30:297-299
23. Räsänen S, Hakko H, Viilo K, Meyer-Rochow VB, Moring J (2003) Excess mortality among long-stay psychiatric patients in Northern Finland. Soc Psychiatry Psychiatr Epidemiol 38:297-304
24. Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 70:19-26
25. Research Triangle Institute (2004) SUDAAN Language Manual, Release 9.0. Research Triangle Park, NC: Research Triangle Institute
26. Ruigomez A, Garcia Rodriguez LA, Dev VJ, Arellano F, Raniwala J (2000) Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 11:620-623
27. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R (2007) Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 42:117-124
28. Schiffman J, Maeda JA, Hayashi K, Michelsen N, Sorensen HJ, Ekstrom M, Abe KA, Chronicle EP, Mednick SA (2006) Premorbid childhood ocular alignment abnormalities and adult schizophrenia-spectrum disorder. Schizophr Res 81:253-260
29. Schubert EW, Henriksson KM, McNeil TF (2005) A prospective study of offspring of women with psychosis: Visual dysfunction in early childhood predicts schizophrenia-spectrum disorders in adulthood. Acta Psychiatr Scand 112:385-393
30. Smith D, Pantelis C, McGrath J, Tangas C, Copolov D (1997) Ocular abnormalities in chronic schizophrenia. Aust N Z J Psychiatry 31:252-256
31. Suvisaari JM, Saarni SI, Perälä J, Suvisaari JVJ, Härkänen T, Lönnqvist J, Reunanen A (2007) Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry 68:1045-1055
32. Toler SM (2004) Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy. Exp Biol Med 229:607-615
33. Ungvari GS, Tang W-K, Wong W-K, Chiu HFK (2002) Distant visual acuity in chronic psychiatric patients. A pilot study. Soc Psychiatry Psychiatr Epidemiol 37:488-491
34. Varma R, Wu J, Chong K, Azen SP, Hays RD (2006) Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113:1846-1853
35. Wolin LR, Dillman A, Meder J, Solymos M (1965) Objective visual acuity of psychotic patients. Int J Neuropsychiatry 1:404-410